List of Excipients in API drospirenone and estradiol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing drospirenone and estradiol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | FERRIC OXIDE RED | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | HYPROMELLOSE | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | LACTOSE MONOHYDRATE | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | MAGNESIUM STEARATE | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | POLYETHYLENE GLYCOL 6000 | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | POVIDONE K25 | |
| Bayer HealthCare Pharmaceuticals Inc | ANGELIQ | drospirenone and estradiol | 50419-483 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for drospirenone and estradiol
Excipient focus: FERRIC OXIDE RED
drospirenone and estradiol drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
drospirenone and estradiol drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
drospirenone and estradiol drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
drospirenone and estradiol drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
drospirenone and estradiol drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MODIFIED CORN STARCH
drospirenone and estradiol drug variants containing MODIFIED CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing MODIFIED CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
drospirenone and estradiol drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
drospirenone and estradiol drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
drospirenone and estradiol drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
drospirenone and estradiol drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
drospirenone and estradiol drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc | drospirenone and estradiol | 50419-483 |
| Physicians Total Care Inc | drospirenone and estradiol | 54868-6184 |
| >Company | >Ingredient | >NDC |
drospirenone and estradiol drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch